| 引用本文: | 王雪,张梦迪,范蕾,白图雅,吕晓丽,胡玉霞,李君,王朝杰,汪涵,常福厚.芳香烃受体和雄激素受体对HepG2细胞中脂质代谢影响的研究[J].中国现代应用药学,2026,43(1):21-26. |
| wangxue,zhang mengdi,fan lei,bai tuya,lv xiaoli,hu yuxia,li jun,wang chaojie,wang han,changfuhou.Effects of Aryl Hydrocarbon Receptor and Androgen Receptor on Lipid Metabolism in HepG2 Cells[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(1):21-26. |
|
| |
|
|
| 本文已被:浏览 3次 下载 0次 |
 码上扫一扫! |
|
|
| 芳香烃受体和雄激素受体对HepG2细胞中脂质代谢影响的研究 |
|
王雪, 张梦迪, 范蕾, 白图雅, 吕晓丽, 胡玉霞, 李君, 王朝杰, 汪涵, 常福厚
|
|
内蒙古医科大学
|
|
| 摘要: |
| 摘要:目的 探究芳香烃受体(Aryl hydrocarbon receptor,AhR)和雄激素受体(Androgen receptor,AR)对HepG2细胞中脂质代谢的影响。方法 将HepG2细胞分为Control组、6-甲酰基吲哚并[3,2-B]咔唑(6-Formylindolo[3,2-b]carbazole,FICZ) (AhR激动剂)组、二氢睾酮(Dihydrotestosterone, DHT) (AR激动剂)组、FICZ+DHT组,按分组分别给予HepG2细胞1 μmol·L-1 FICZ及1 μmol·L-1DHT。试剂盒检测TG、TC和 LDL-C含量,油红O染色法检测脂质含量,尼罗红染色法检测脂质荧光强度。Western blot法检测胆固醇合成相关基因3-羟基-3-甲基戊二酸还原酶(3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase,HMGCR)、固醇调节元件结合蛋白2(Sterol regulatory element-binding protein 2,SREBP2)、肝X受体α(Liver X Receptor alpha,LXRα)和脂肪酸合成的相关基因CCAAT增强子结合蛋白α(CCAAT Enhancer Binding Protein alpha,C/EBPα)、过氧化物酶体增殖物激活受体γ(Peroxisome proliferator-activated receptor?γ,PPARγ)和硬脂酰辅酶A去饱和酶1(Stearoyl-CoA Desaturase 1,SCD1)蛋白的表达情况。结果 与Control组相比,FICZ组HepG2细胞中脂质含量上升,DHT组HepG2细胞中脂质含量降低;与FICZ组相比,FICZ+DHT组HepG2细胞中脂质含量降低。与Control组相比,FICZ组HMGCR、SREBP2、LXR蛋白表达增加;DHT组HMGCR、SREBP2、LXRα蛋白表达减少;与FICZ组相比,FICZ+DHT组HMGCR、SREBP2、LXRα蛋白表达减少。与Control组相比,FICZ组SCD1、C/EBPα、PPARγ蛋白表达增加;DHT组SCD1、C/EBPα、PPARγ蛋白表达减少;与FICZ组相比,FICZ+DHT组SCD1、C/EBPα、PPARγ蛋白表达减少,差异具有统计学意义。结论 AhR和AR存在相互作用,对脂质代谢的影响呈相互拮抗。 |
| 关键词: 芳香烃受体 雄激素受体 脂质代谢 6-甲酰基吲哚并[3,2-B]咔唑 二氢睾酮 |
| DOI: |
| 分类号:R284.1;R917.101?????? |
| 基金项目:国家自然科学基金(82260733);内蒙古自治区自然科学基金项目(2023QN08016);中央引导地方科技发展资金(2022ZY0222);内蒙古医科大学科技百万工程项目(YKD2020KJBW020) |
|
| Effects of Aryl Hydrocarbon Receptor and Androgen Receptor on Lipid Metabolism in HepG2 Cells |
|
wangxue, zhang mengdi, fan lei, bai tuya, lv xiaoli, hu yuxia, li jun, wang chaojie, wang han, changfuhou
|
|
Inner Mongolia Medical University
|
| Abstract: |
| ABSTRACT: OBJECTIVE To investigate the effects of aryl hydrocarbon receptor (AhR) and androgen receptor (AR) on lipid metabolism in HepG2 cells. METHODS HepG2 cells were divided into Control group, 6-Formylindolo[3,2-b]carbazole (FICZ) (AhR agonist) group,Dihydrotestosterone (DHT) (AR agonist) group, and FICZ+DHT group. HepG2 cells were given 1 μmol·L-1 FICZ and 1 μmol·L-1 DHT according to the groups. Kits were used to detect the levels of TG, TC and LDL-C, Oil Red O staining was used to detect lipid content, and Nile Red staining was used to detect lipid fluorescence intensity. Western blot was used to detect the expression of cholesterol synthesis-related genes 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR), Sterol regulatory element-binding protein 2 (SREBP2), Liver X Receptor alpha (LXRα) and fatty acid synthesis-related genes CCAAT Enhancer Binding Protein alpha (C/EBPα), Peroxisome proliferator-activated receptor?γ (PPARγ) and Stearoyl-CoA Desaturase 1 (SCD1) proteins. RESULTS Compared with the Control group, the lipid content in HepG2 cells in the FICZ group increased, and the lipid content in HepG2 cells in the DHT group decreased; compared with the FICZ group, the lipid content in HepG2 cells in the FICZ+DHT group decreased. Compared with the Control group, the expression of HMGCR, SREBP2, and LXRα proteins in the FICZ group increased; the expression of HMGCR, SREBP2, and LXRα proteins in the DHT group decreased; compared with the FICZ group, the expression of HMGCR, SREBP2, and LXRα proteins in the FICZ+DHT group decreased. Compared with the Control group, the expression of SCD1, C/EBPα, and PPARγ proteins in the FICZ group increased; the expression of SCD1, C/EBPα, and PPARγ proteins in the DHT group decreased; compared with the FICZ group, the expression of SCD1, C/EBPα, and PPARγ proteins in the FICZ+DHT group decreased, and the differences were statistically significant. CONCLUSION AhR and AR interact with each other and their effects on lipid metabolism are antagonistic. |
| Key words: aryl hydrocarbon receptor androgen receptor lipid metabolism 6-Formylindolo[3,2-b]carbazole dihydrotestosterone |
|
|
|
|